Nektar Therapeutics
USD69.81
+4.42 (+6.76%)
CEO
Howard W. Robin
IPO Date
1994-05-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$66.39
Prev. Close
$65.39
Day Low
$66.39
Day High
$71.50
52W Low
$21.02
52W High
$109.00
Market Cap
$1.36B
Volume
1.57M
| -1.6 |
| 31 Dec 2023 | FY | 59.3% | -306.3% | -210.8% | -69.4% | 0.90 | 6.45 | -0.4 |
| 31 Dec 2022 | FY | 76.5% | -400.0% | -100.4% | -51.8% | 0.36 | 8.00 | -1.1 |
| 31 Dec 2021 | FY | 75.6% | -514.0% | -77.1% | -46.9% | 0.21 | 9.34 | -4.7 |
| 31 Dec 2020 | FY | 87.3% | -290.6% | -41.3% | -28.9% | 0.14 | 9.83 | -6.8 |
| 31 Dec 2019 | FY | 81.4% | -384.5% | -31.4% | -22.3% | 0.29 | 4.02 | -8.6 |
| 31 Dec 2018 | FY | 98.0% | 57.1% | 39.7% | 31.7% | 0.14 | 17.53 | 8.7 |
| 31 Dec 2017 | FY | 90.1% | -31.4% | -110.1% | -19.0% | 2.79 | 5.82 | -96.3 |
| 31 Dec 2016 | FY | 81.7% | -92.8% | -174.2% | -27.0% | 2.82 | 5.90 | -11.2 |
| -5.9 |
| 30 Sept 2025 | Q3 | 98.3% | -301.3% | -41.7% | -11.8% | 1.08 | 4.24 | -5.6 |
| 30 Jun 2025 | Q2 | 100.0% | -372.2% | 171.8% | -20.0% | -3.97 | 2.61 | -2.2 |
| 31 Mar 2025 | Q1 | 100.0% | -486.4% | -370.4% | -19.9% | 7.30 | 3.24 | -0.7 |
| 31 Dec 2024 | Q4 | 72.7% | 24.9% | 12.0% | 2.4% | 1.69 | 4.26 | 6.7 |
| 30 Sept 2024 | Q3 | 81.6% | -153.6% | -75.8% | -12.0% | 2.21 | 4.24 | -1.8 |
| 30 Jun 2024 | Q2 | 58.5% | -222.9% | -65.7% | -15.3% | 2.76 | 5.15 | -1.2 |
| 31 Mar 2024 | Q1 | 60.6% | -170.1% | -29.0% | -9.3% | 0.90 | 6.10 | -1.2 |
| 31 Dec 2023 | Q4 | 69.5% | -176.2% | -32.1% | -10.6% | 0.90 | 6.45 | -0.6 |